95 related articles for article (PubMed ID: 20389167)
1. Apoptotic action of botulinum toxin on detrusor muscle in rats.
Watanabe T; Masago T; Miyagawa I
Urol Int; 2010; 84(3):341-6. PubMed ID: 20389167
[TBL] [Abstract][Full Text] [Related]
2. Novel action of botulinum toxin on the stromal and epithelial components of the prostate gland.
Chuang YC; Huang CC; Kang HY; Chiang PH; Demiguel F; Yoshimura N; Chancellor MB
J Urol; 2006 Mar; 175(3 Pt 1):1158-63. PubMed ID: 16469644
[TBL] [Abstract][Full Text] [Related]
3. The effects of botulinum-A toxin on bladder function and histology in spinal cord injured rats: is there any difference between early and late application?
Temeltas G; Tikiz C; Dagci T; Tuglu I; Yavasoglu A
J Urol; 2005 Dec; 174(6):2393-6. PubMed ID: 16280854
[TBL] [Abstract][Full Text] [Related]
4. Effect of botulinum toxin on detrusor overactivity induced by intravesical adenosine triphosphate and capsaicin in a rat model.
Atiemo H; Wynes J; Chuo J; Nipkow L; Sklar GN; Chai TC
Urology; 2005 Mar; 65(3):622-6. PubMed ID: 15780404
[TBL] [Abstract][Full Text] [Related]
5. Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type a in overactive neurogenic bladder.
Haferkamp A; Schurch B; Reitz A; Krengel U; Grosse J; Kramer G; Schumacher S; Bastian PJ; Büttner R; Müller SC; Stöhrer M
Eur Urol; 2004 Dec; 46(6):784-91. PubMed ID: 15548448
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis.
Schulte-Baukloh H; Schobert J; Stolze T; Stürzebecher B; Weiss C; Knispel HH
Neurourol Urodyn; 2006; 25(2):110-5. PubMed ID: 16470519
[TBL] [Abstract][Full Text] [Related]
7. Effect of botulinum toxin on expression of nerve growth factor and transient receptor potential vanilloid 1 in urothelium and detrusor muscle of rats with bladder outlet obstruction-induced detrusor overactivity.
Ha US; Park EY; Kim JC
Urology; 2011 Sep; 78(3):721.e1-721.e6. PubMed ID: 21782224
[TBL] [Abstract][Full Text] [Related]
8. Botulinum-A toxin detrusor and sphincter injection in treatment of overactive bladder syndrome: objective outcome and patient satisfaction.
Schulte-Baukloh H; Weiss C; Stolze T; Herholz J; Stürzebecher B; Miller K; Knispel HH
Eur Urol; 2005 Dec; 48(6):984-90; discussion 990. PubMed ID: 16126328
[TBL] [Abstract][Full Text] [Related]
9. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra.
Smith CP; Nishiguchi J; O'Leary M; Yoshimura N; Chancellor MB
Urology; 2005 Jan; 65(1):37-41. PubMed ID: 15667859
[TBL] [Abstract][Full Text] [Related]
10. Increased efficacy and decreased systemic-effects of botulinum toxin A injection after active or passive muscle manipulation.
Minamoto VB; Hulst JB; Lim M; Peace WJ; Bremner SN; Ward SR; Lieber RL
Dev Med Child Neurol; 2007 Dec; 49(12):907-14. PubMed ID: 18039237
[TBL] [Abstract][Full Text] [Related]
11. Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?
Sahai A; Sangster P; Kalsi V; Khan MS; Fowler CJ; Dasgupta P
BJU Int; 2009 Mar; 103(5):630-4. PubMed ID: 18990156
[TBL] [Abstract][Full Text] [Related]
12. Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?
Kessler TM; Danuser H; Schumacher M; Studer UE; Burkhard FC
Neurourol Urodyn; 2005; 24(3):231-6. PubMed ID: 15747344
[TBL] [Abstract][Full Text] [Related]
13. Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity.
Giannantoni A; Di Stasi SM; Nardicchi V; Zucchi A; Macchioni L; Bini V; Goracci G; Porena M
J Urol; 2006 Jun; 175(6):2341-4. PubMed ID: 16697870
[TBL] [Abstract][Full Text] [Related]
14. Growth effects of botulinum toxin type A injected into masseter muscle on a developing rat mandible.
Kim JY; Kim ST; Cho SW; Jung HS; Park KT; Son HK
Oral Dis; 2008 Oct; 14(7):626-32. PubMed ID: 18331419
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin for detrusor overactivity and symptoms of overactive bladder: where we are now and where we are going.
Sahai A; Khan MS; Gregson N; Smith K; Dasgupta P;
Nat Clin Pract Urol; 2007 Jul; 4(7):379-86. PubMed ID: 17615549
[TBL] [Abstract][Full Text] [Related]
16. Experience with injections of botulinum toxin type A into the detrusor muscle.
Miyagawa I; Watanabe T; Isoyama T; Honda M; Kobayasi N; Hikita K; Saito M; Hirakawa S
Aktuelle Urol; 2010 Jan; 41 Suppl 1():S24-6. PubMed ID: 20094947
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
[TBL] [Abstract][Full Text] [Related]
18. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.
Akbar M; Abel R; Seyler TM; Bedke J; Haferkamp A; Gerner HJ; Möhring K
BJU Int; 2007 Sep; 100(3):639-45. PubMed ID: 17532858
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation.
Lucioni A; Bales GT; Lotan TL; McGehee DS; Cook SP; Rapp DE
BJU Int; 2008 Feb; 101(3):366-70. PubMed ID: 18184328
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
Schurch B; de Sèze M; Denys P; Chartier-Kastler E; Haab F; Everaert K; Plante P; Perrouin-Verbe B; Kumar C; Fraczek S; Brin MF;
J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]